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Hemoglobin (Hb) continuously undergoes autoxidation producing superoxide which
dismutates into hydrogen peroxide (H2O2) and is a potential source for subsequent
oxidative reactions. Autoxidation is most pronounced under hypoxic conditions in the
microcirculation and for unstable dimers formed at reduced Hb concentrations. In
the red blood cell (RBC), oxidative reactions are inhibited by an extensive antioxidant
system. For extracellular Hb, whether from hemolysis of RBCs and/or the infusion of
Hb-based blood substitutes, the oxidative reactions are not completely neutralized by
the available antioxidant system. Un-neutralized H2O2 oxidizes ferrous and ferric Hbs to
Fe(IV)-ferrylHb and OxyferrylHb, respectively. FerrylHb further reacts with H2O2 producing
heme degradation products and free iron. OxyferrylHb, in addition to Fe(IV) contains a
free radical that can undergo additional oxidative reactions. Fe(III)Hb produced during Hb
autoxidation also readily releases heme, an additional source for oxidative stress. These
oxidation products are a potential source for oxidative reactions in the plasma, but to a
greater extent when the lower molecular weight Hb dimers are taken up into cells and
tissues. Heme and oxyferryl have been shown to have a proinflammatory effect further
increasing their potential for oxidative stress. These oxidative reactions contribute to a
number of pathological situations including atherosclerosis, kidney malfunction, sickle
cell disease, and malaria. The toxic effects of extracellular Hb are of particular concern
with hemolytic anemia where there is an increase in hemolysis. Hemolysis is further
exacerbated in various diseases and their treatments. Blood transfusions are required
whenever there is an appreciable decrease in RBCs due to hemolysis or blood loss.
It is, therefore, essential that the transfused blood, whether stored RBCs or the blood
obtained by an Autologous Blood Recovery System from the patient, do not further
increase extracellular Hb.
Keywords: extracellular hemoglobin, hemoglobin autoxidation, oxidative reactions, hydrogen peroxide, heme,
Fe(IV)hemoglobins, proinflammatory reactions
INTRODUCTION
The functional role of Red Blood Cells (RBCs) is the transport
of oxygen from the lungs to the tissues providing the oxygen
required by all cells and tissues. Hemoglobin (Hb) accounts
for 95–97% of the cytosolic proteins inside the RBC, and the
reversible binding of oxygen to Hb provides the mechanism for
oxygen transport by the RBC. Oxygen binds to Hb in the lungs
at high partial pressures of oxygen and is released to the tissues at
reduced partial pressures of oxygen in themicrocirculation. There
is, however, a continuous slow autoxidation of Hb when bound
to oxygen producing superoxide that converts functional Hb-
Fe(II) into oxidized Hb-Fe(III), which no longer binds oxygen
(Equation 1).
Hb-Fe(II)O2 ↔ Hb-Fe(III) + O·−2 (1)
Hydrogen peroxide (H2O2) is produced during Hb autoxidation
by the spontaneous and enzyme driven dismutation of superoxide
(Equation 2).
2O·−2 + 2H+ → H2O2 + O2 (2)
In an intact RBC there are enzymes that reduce oxidized Hb
back to functional Fe(II)-Hb. In addition, the reactive oxygen
species (ROS), H2O2 and superoxide, are neutralized by the
extensive RBC antioxidant system involving both non-enzymatic
low molecular weight antioxidants like glutathione, Vitamin E,
and ascorbic acid and enzymatic antioxidants including super-
oxide dismutase, catalase (Gonzales et al., 1984), glutathione
peroxidase (Nagababu et al., 2003), and peroxiredoxin-2 (Lee
et al., 2003; Nagababu et al., 2013). Considering the large pool
of Hb and the constant slow autoxidation reaction, the intact
RBC protects the body from a potential major source of oxidative
stress.
The only non-neutralized ROS generated by intact RBCs
involves the small fraction of Hb that binds to the RBC mem-
brane. ROS generated near themembrane are less accessible to the
cellular antioxidant system, which is primarily located in the cyto-
plasm. Furthermore, these ROS are being generated where they
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can damage the RBC membrane and/or be released from the cell
to damage other cells and tissues.
The contribution of hemoglobin-membrane interactions is
amplified in the microcirculation where Hb is partially oxy-
genated. Partial oxygenation results in a Hb conformational
change that produces a dramatic increase in the rate of autox-
idation and the affinity of Hb for the RBC membrane (Cao
et al., 2009). The increased autoxidation of cytoplasmic Hb and
subsequent generation of ROS can still be neutralized by the
cytoplasmic antioxidant system. However, partial oxygenation
produces a significant increase in the formation of ROS at the
membrane. The potential source for oxidative stress involving
membrane binding is, nevertheless, limited by the fact that even
under optimal conditions less than 1% of the intracellular Hb can
interact with the membrane at any time.
EXTRACELLULAR HEMOGLOBIN AS A SOURCE FOR
OXIDATIVE STRESS
Extracellular Hb, whether originating from hemolysis of RBCs
or the infusion of cell-free Hb-based blood substitutes, can be a
major source for oxidative stress. Under normal conditions this
potential source of oxidative stress is minimized by haptoglobin
and hemopexin, which bind Hb and free heme, respectively. They
inhibit the oxidative reactions of Hb and heme and facilitate their
removal from circulation. Elevated levels of free extracellular Hb
and heme, which cannot be neutralized by reacting with hap-
toglobin and hemopexin, have been shown to produce multiple
adverse clinical effects.
Themechanisms for these pathophysiological effects have been
extensively discussed. A great deal of interest in recent years has
been directed at the reaction of NO with Hb (Rother et al.,
2005), which reduces the level of NO available for many essen-
tial functions. These include regulation of vascular tone, smooth
muscle relaxation, neutrophil adhesion to endothelial cells (EC)
and platelet activation. The scavenging of NO by extracellular Hb
clearly has significant pathological effects.
However, the pathological effects involving oxidative reactions
of extracellular Hb also need to be considered.
INCREASED AUTOXIDATION
The oxidative reactions, which occur in RBCs, are greatly ampli-
fied at the membrane site where intracellular antioxidant system
becomes inefficient. The potential oxidative stress resulting from
extracellular Hb is further exacerbated by a dramatic increase in
rates of autoxidation for partially oxygenated Hb formed in the
microcirculation, as well as an increase in the rate of autoxida-
tion of Hb dimers formed when the Hb tetramer dissociates into
dimers (Figure 1) at the reduced Hb concentration in plasma
(Zhang et al., 1991). The lower molecular weight of Hb dimers
also facilitates the translocation of Hb from the circulation to the
vasculature and other tissues sensitive to Hb oxidative reactions
(Figure 1).
With extracellular Hb we not only need to deal with the autox-
idation reaction and the resultant formation of superoxide and
H2O2, but we need to consider the secondary oxidative reactions
involving reactions of H2O2 with Hb. It has also been shown that
a direct reaction of H2O2 with the iron of Fe(II)-hemoglobin can
undergo a Fenton reaction producing the highly reactive hydroxyl
radical (Equation 3) (Sadrzadeh et al., 1984).
H2O2 + Fe(II) → ·OH + OH− + Fe(III) (3)
The potential significance of this reaction is indicated by the
reported detection of hydroxyl radicals in sickle erythrocytes
(Hebbel, 1985). Because of their high reactivity any formation of
hydroxyl radicals can produce cellular and tissue damage.
SECONDARY OXIDATION REACTIONS INVOLVING RELEASE OF HEME
AND FORMATION OF FERRYL HEMOGLOBINS
The two electron oxidation of Fe(II)-Hb by H2O2 (Equation 4)
produces the Fe(IV)-ferrylHb (Figure 1).
Hb(II) + H2O2 → Hb(IV)=O (4)
Although the ferrylHb can be a source for oxidative damage, toxic
effects due to reactions of ferrylHb have not been demonstrated.
However, ferrylHb has been shown to react with an additional
molecule of H2O2 (Equation 5)
Hb(IV)=O + H2O2 → Hb(III) + O·−2 → heme degradation
products + Fe(III) (5)
resulting in the degradation of the heme and the release of flu-
orescent heme degradation products and free iron (Figure 1)
(Nagababu and Rifkind, 1998, 2000). An increase in these heme
degradation products has been shown to indicate an increase in
oxidative stress (Nagababu et al., 2008a,b), even though specific
toxic reactions involving these products have not been estab-
lished. However, increased Fenton chemistry involving free iron
has been well established (Winterbourn, 1995) and the reported
increase in free iron for various pathologies, may have originated
from this heme degradation reaction (Nagababu and Rifkind,
1998).
The increased formation of superoxide and H2O2 due to
autoxidation of extracellular Hb, also results in the oxidation
of the functional ferrous Hb to Fe(III)metHb (Equation 1).
Although high concentrations of metHb (hemoglobinuria) are
associated with renal dysfunction (Tracz et al., 2007), direct
pathological effects of Fe(III)Hb have not been established.
However, the heme, which has a lower affinity for metHb than
ferrous Hb dissociates from metHb (Bunn and Jandl, 1968)
(Figure 1). Heme, a low molecular weight hydrophobic molecule
is taken up by cell membranes, plasma proteins, and lipids. Its
reaction with low-density lipoproteins has been reported to pro-
duce the more toxic oxidized low-density lipoprotein (Balla et al.,
1991). Associated with plasma proteins like albumin it is also
trans-located to various tissues (Schaer et al., 2013), where it
can further generate toxic effects. Heme can bind to certain
receptors, transcription factors, and enzymes. These interactions
can alter cellular function, metabolism, and gene transcription.
The altered gene transcription is the basis for a heme induced
proinflammatory effect (Figure 1) (Wagener et al., 2001b).
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FIGURE 1 | Scheme illustrating the various reactions that take place with extracellular hemoglobin.
The two electron oxidation of Fe(III)Hb by H2O2 produces
oxyferrylHb
Hb(III) + H2O2 → ·Hb(IV)=O + H2O (6)
The oxyferrylHb is unstable with the unpaired electron migrat-
ing to the globin with the formation of radicals involving tyr-24,
tyr-42, and his-20 of the alpha chain and tyr-35, tyr-130, and
cys-93 of the beta chain (Deterding et al., 2004). These products
are highly reactive and have been shown to produce crosslinked
Hb multimers (Nagy et al., 2010). OxyferrylHb, like metHb,
has been shown to release heme. However, oxyferryl and/or the
resultantmultimers without dissociating heme act as a proinflam-
matory agonist attacking the vascular endothelium (Silva et al.,
2009).
Both heme and oxyferrylHb have been reported to be proin-
flammatory agonists (Figure 1) resulting in the activation of
the redox sensitive transcription factor NF-κB. However, two
different pathways are involved. The proinflammatory effect of
oxyferrylHb is triggered by interactions of multimeric hydropho-
bic aggregates recognized by innate receptors (Silva et al., 2009).
This disrupts membranes and triggers inflammation via an
IL-1/1L-1Ra signal transduction pathway. Heme, however, can
bind to TLR4 (Teng et al., 2009). The interaction with TLR4
induces activation of NF-κB (Lin et al., 2012).
PATHOLOGICAL EFFECTS ASSOCIATED WITH HEMOGLOBIN
OXIDATIVE REACTIONS
In attempting to evaluate the pathological effects of oxidative
reactions involving extracellular Hb, the first area to look at are
effects on the plasma lipoproteins and the vasculature, which Hb
comes directly in contact with.
LIPOPROTEINS AND THE VASCULATURE
Oxidation of low density lipoproteins (LDL) is thought to play
an important role in initiating atherogenesis (Steinbrecher et al.,
1984). The oxidation of LDL is triggered by the uptake of heme
by LDL. It has been reported that the LDL, which is highly
hydrophobic, is able to compete with hemopexin and albumin for
the free heme, with 80% of heme added to plasma immediately
taken up by lipoproteins (Miller and Shaklai, 1999). The LDL
oxidative reactions involve low levels of lipid hydroperoxides or
oxidants, which lead to oxidative degradation of the heme and the
release of heme iron (Sadrzadeh and Eaton, 1988). It is thought
that it is this free iron that results in the accelerated oxidation of
polyunsaturated fatty acids and other components of the LDL.
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The atherosclerotic plaques and particularly disruptured
plaques have been shown (Nagy et al., 2010) to lyse RBCs and
oxidize the released Hb producing metHb, free heme, free iron
and the Fe(IV)Hb oxidized product, oxyferrylHb. Dityrosine and
cross-linked hemoglobins produced as a result of the formation
of oxyferrylHb are also detected. In addition to the heme released
from metHb, it has been shown that heme is released from oxy-
ferrylHb. The enhanced release of heme and free iron due to the
interaction of plaque with RBCs further amplify the oxidation of
plaque components that results in cytotoxic reactions affecting
the endothelium (Nagy et al., 2010).
The oxidative reactions discussed are thought to primarily
involve the release of heme and iron. However, in vitro studies
have demonstrated that oxyferrylHb also acts as a proinflam-
matory agonist (Silva et al., 2009). In vitro studies have shown
that oxyferrylHb induces the formation of F-actin stress fibers
resulting in the formation of intercellular gaps disrupting the
integrity of the endothelium. This results in extravascular leak-
age. This leakage activates the κB family of transcription factors
inducing the expression of proinflammatory genes like E-selectin,
ICAM-1, and VCAM-1. In addition, oxyferrylHb activates the sig-
nal transduction pathways involving p38 MAPK and JNK. This
proinflammatory response was shown to increase EC permeabil-
ity and enhance monocyte adhesion. The combined oxidative
effects due to both metHb, oxyferrylHb, and free heme increase
oxidation of plaque lipids, while the proinflammatory effects of
oxyferrylHb trigger endothelial cytotoxicity. Together, these pro-
cesses play a significant role in the pathology associated with
atherosclerosis.
RENAL DYSFUNCTION
In addition to the oxidative reactions involving lipoproteins and
the vasculature, renal dysfunction is a major pathology that
results from oxidative reactions associated with extracellular Hb.
This pathology is triggered by the uptake of Hb dimers by the
kidney glomerulus. Hb dimers are formed from extracellular Hb
due to the dissociation of tetrameric Hb into dimers (Ackers and
Halvorson, 1974) at the reduced Hb concentration in plasma. The
reduced molecular weight of the Hb dimers (32-kD instead of 64-
kD) facilitates their transfer into tissues. However, the uptake of
Hb dimers is most pronounced in the kidney that is designed to
remove free Hb from the circulation.
As discussed above, the extensive RBC antioxidant system
severely limits oxidative reactions involving intracellular Hb. The
antioxidant capacity of plasma is appreciably less relative to that
of the RBCs. Nevertheless, the reducing ability of ascorbic acid
and urate in plasma results in relatively low levels of oxidized
Hb in plasma (Butt et al., 2010). Hb dimers translocated into the
kidney, experience amuch harsher oxidative environment as indi-
cated by the high levels of metHb in the urine when elevated cell
free Hb is present (Boretti et al., 2009). The increased Hb oxida-
tion in the kidney also results in the subsequent release of free
heme. Free heme in the kidney as well as other organs induce
heme oxygenase-1, which converts heme to bilirubin with antiox-
idant activities (Stocker et al., 1987). Excess heme in the kidney
as well as other organs and tissues produce a number of cytotoxic
effects.
The hydrophobic heme in cellular membranes can oxidize
lipids, denature proteins, and perturb the integrity of the attached
cytoskeleton. Heme can oxidatively denature DNA and impair
the activity of cytosolic enzymes including glucose-6-phosphate
dehydrogenase and glutathione reductase. Heme can also activate
cell-damaging enzymes such as caspases and cathepsins (Tracz
et al., 2007). Heme affects mitochondrial function with an initial
increase in respiration followed by a decrease and ultimate cessa-
tion of oxygen consumption (Nath et al., 1998). Even relatively
low levels of heme become cytotoxic in the presence of H2O2,
which can degrade the heme producing free iron.
In addition to the direct oxidative reactions involving the
heme, elevated heme levels have also been shown to have a proin-
flammatory effect (see above). Studies involving the vasculature
(Silva et al., 2009) suggest that metHb does not have a proin-
flammatory effect and that reported effects due to metHb (Liu
and Spolarics, 2003; Silva et al., 2009) can be due to endo-
toxin contamination. There is, however, clear evidence that heme,
which readily dissociates from metHb, does have a proinflam-
matory effect even in the absence of endotoxin (Fortes et al.,
2012).
The heme induced proinflammatory effect in the kidney
induces the chemokine monocyte chemo-attractant protein-1
(MCP-1) and transforming growth factor b1 isoform1 (TGF-
beta-1) by activating the redox sensitive transcription factor NF-
κB (Kanakiriya et al., 2003). The resultant increased levels of the
chemokines and other proinflammatory reactions, are thought
to contribute to tubule-interstitial disease (Qian et al., 2010),
decreased renal perfusion and intra-tubular casts formed by the
interaction of heme proteins with Tamm-Horsfall protein (Tracz
et al., 2007). Pathology of Tamm-Horsfall protein (Hoyer and
Seiler, 1979) can result in chronic renal dysfunction.
OTHER TOXIC EFFECTS DUE TO HEMOGLOBIN OXIDATIVE REACTIONS
While these effects are generally most pronounced in the kid-
ney, which plays a major role on removing the extracellular Hb
from the body, similar affects are observed in other tissues where
Hb is translocated from the plasma into tissues and exposed to
increased oxidative conditions. Proinflammatory effects of free
heme have been shown to induce up-regulation of adherence
molecules in other organs including the gut, liver, and pan-
creas (Wijayanti et al., 2004). This increased adherence results
in leukocyte recruitment and increased vascular permeability
(Wagener et al., 2001b). These effects are particularly relevant in
diseased and inflamed tissues or after an ischemic insult when
other oxidants are present in the tissue. Heme proinflammatory
effects have also been shown to induce programmed necro-
sis on macrophages (Fortes et al., 2012) and to be involved in
intracerebral hemorrhage (Simoes et al., 2013). In sickle cell
disease, it has been shown that heme released into the circula-
tion causes expression of endothelial adhesion molecules, which
results in increased adhesion of leukocytes and reticulocytes to
the endothelium (Wagener et al., 2001a). It has also been shown
that free heme precipitates severe malaria and particularly cere-
bral malaria (Ferreira et al., 2008). This is associated with the
disruption of the blood brain barrier and adhesion of infected
RBCs to the brain microvascular endothelium. These processes
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are thought to involve ROS, but the adherence could involve
the heme induced inflammatory response. In conclusion, the
combined effects of intrinsic oxidative reactions and oxidative
reactions triggered as a result of inflammation have an important
role in the pathology that results from increased concentrations
of extracellular Hb.
PHYSIOLOGICAL SOURCES FOR CELL FREE HEMOGLOBIN
Under normal conditions minimal lysis of RBCs occur before the
aged cells are removed from circulation. The level of cell free Hb
in circulation is, therefore, minimal. Increased levels of extra-
cellular Hb occur when the rate of RBC lysis increases and the
removal of extracellular Hb from circulation are slower than the
production of additional Hb from cell lysis.
Increased RBC lysis in vivo occurs due to one of two classes of
pathological situations.
(1) Modifications of the RBC that decrease its stability and
increase lysis as the cells flow through the circulatory system.
These changes generally involve alteration of the genes that con-
trol RBC production and function. This can affect the Hb, the
RBC membrane or enzymes required for proper function of the
RBC. For example, in Sickle Cell Anemia and Thalassemia the
altered Hbs are less stable resulting in increased intracellular
oxidative reactions that damage the cell membrane and increase
RBC lysis (Nagababu et al., 2008a). Sickle cell anemia involves
a mutation on the B6 residue that results in a tendency for the
hemoglobin to aggregate resulting in an appreciable shorter cell
lifetime (Wagener et al., 2001a). In Thalassemia, adequate levels
of the alpha chain or beta chain are not produced and thus there
is disruption of the stable quaternary structure of Hb (Kidd et al.,
2001), resulting in impaired stability and increased RBC lysis.
Examples of altered membrane structure are Hereditary
Spherocytosis and Hereditary Elliptocytosis, in which the shape
of the RBC is spherical and elliptical, respectively, instead of
the normal biconcave shaped cells (Da et al., 2013). The altered
cells are less deformable and have difficulty passing through the
narrow capillaries in the microcirculation resulting in increased
cell lysis. Paroxysmal Nocturnal Hemoglobinuria also results in
altered RBC membrane structure (Basu et al., 2010) that results
in increased clots in the veins.
Examples of altered enzyme activity that affect the ability
of RBCs to withstand oxidative stress are glucose-6-phosphate
dehydrogenase (G6PD) deficiency (Rochford et al., 2013) and
pyruvate kinase deficiency (Abdel et al., 2010). G6PD plays an
essential role in the phosphate shunt that helps maintain the RBC
antioxidant activity and pyruvate kinase is an essential enzyme
involved in glucose metabolism and the production of ATP. The
resultant altered metabolic activity results in increased oxidative
stress and increased cell lysis.
In vitro or in vivo processes that stress the RBC membranes
contribute to mechanical hemolytic anemia. This process is anal-
ogous to the increased lysis that occurs in certain abnormal
Hbs with altered cell shape (see above) and with sickle cell dis-
ease where the sickling produces a decrease in deformability. A
number of treatments used also mechanically stress the RBC
membrane and can induce increased lysis. This includes an arti-
ficial heart valve, hemodialysis for kidney failure, heart lung
bypass machine used for open-heart surgery, preeclampsia, and
malignant hypertension.
(2) Situations where the RBCs may be normal but diseases
cause the RBCs to be lysed. Autoimmune Hemolytic Anemia
(AIHA) is a situation where the immune systemmakes antibodies
that attack the RBC (Wakui et al., 1988). Although what trig-
gers AIHA is not known, certain diseases or infections involving
inflammation such as lupus, hepatitis, and HIV increase the risk
for AIHA. Alloimmune hemolytic anemia (Odabas et al., 2002)
involves antibodies made against blood obtained from a blood
transfusion, if the transfused blood is of a different type than
that of the patient. Drug-induced hemolytic anemia is induced
by certain medicines such as those used in chemotherapy or
medicines used to treat malaria. Many disease situations that
result in increased oxidative reactions/inflammation in specific
tissues can cause lysis of the RBCs when the RBCs come in con-
tact with these inflamed tissues. For example, RBC lysis is induced
when they come in contact with atherosclerotic tissue (see above).
The increased extracellular Hb resulting from hemolytic ane-
mia is amplified by the frequent infusion of blood to compensate
for the reduced RBC content and the resultant impaired delivery
of oxygen. The required infusion of blood is most pronounced
during surgeries that involve an appreciable loss of blood.
Initially prompted by the need for a source of blood available
in the battlefield where whole blood is not available, a number
of studies focused on the use of Hb based blood substitutes. The
Hb in these blood substitutes were modified to adjust the oxygen
affinity to that of whole blood and cross-linked forming higher
molecular aggregates to prevent the rapid removal of cell free Hb
by the kidneys. The initial failure to consider the difficulties asso-
ciated with cell-free Hb involving both NO complexation and
oxidative reactions resulted in very limited use of Hb based blood
substitutes until modification can be put in place to minimize
these serious side effects.
The two sources of blood that is currently in use involve
(1) stored whole blood collected from volunteers and (2) RBCs
obtained from an Autologous Blood Recovery System like “Cell
Saver” (Ottesen and Froysaker, 1982). Cell Saver blood is collected
from patients during surgeries involving a major loss of blood.
Since this Cell Saver blood has anticoagulant added, cells are
washed to remove excess anticoagulant, plasma, platelets, leuko-
cytes, and any free Hb. The washed and packed RBCs are then
suspended in saline to a 50% hematocrit and transferred to a
transfer pack for reinfusion when needed. If necessary, the rein-
fusion can occur less than 10min after the collection of the blood
(Keeling et al., 1983).
Blood, even in vivo, has a limited lifespan of 120 days. After
removal from the circulation there are metabolic and oxidative
changes that begin to take place immediately. To minimize these
effects blood is stored in a media that is supposed to minimize
these effects. Currently the FDA permits the use of stored blood
for 42 days. Recent studies, however, indicate increased oxidative
reactions as well as instability of the RBC membrane resulting in
increased rates of lysis and more rapid removal from circulation
well before 42 days storage (Wang et al., 2012).
Cell Saver RBCs are from patient’s fresh blood and there-
fore minimizes the major metabolic and oxidative difficulties
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associated with stored blood. However, recent studies (Gueye
et al., 2010) indicate that these cells are, nevertheless, suscepti-
ble to lysis and the production of extracellular Hb. Some of the
reported increase in lysis can be related to the fact that we are
using blood of patients with various diseases, which presumably
involve increased inflammation and oxidative stress.
Considering the major difficulties associated with extracellular
Hb, additional studies are crucial. For stored blood methods to
extend the stability of the stored RBCs are essential. For Cell Saver
blood cells where we are dealing with fresh blood it is essential to
identify the source for any increased lysis and develop methods to
minimize lysis and the formation of extracellular Hb.
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